Genetic ablation of Rack1 in SHH‐subtype medulloblastoma (MB) tumor mice could significantly reduce tumor cell proliferation, reduce the tumor size, and prolong the survival of tumor rescue mice, indicating that Rack1 may serve as a potential novel therapeutic target for SHH‐type MB in the clinic. This evidence concerns the gene RACK1 and neoplasm.